Cargando…

The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study

AIMS: Fabry disease is an X-linked lysosomal storage disorder due to a deficiency of the α-galactosidase A enzyme. Cardiac involvement is present in over 60% of adult cases of Fabry disease. Hypertrophic cardiomyopathy without left ventricular outflow tract obstruction is the most common phenotype....

Descripción completa

Detalles Bibliográficos
Autores principales:	Barman, Hasan Ali, İkitimur, Barış, Kılıçkıran Avcı, Burçak, Durmaz, Eser, Atıcı, Adem, Aslan, Serkan, Ceylaner, Serdar, Karpuz, Hakan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835159/ https://www.ncbi.nlm.nih.gov/pubmed/31446751 http://dx.doi.org/10.4274/balkanmedj.galenos.2019.2019.5.125

Ejemplares similares

The clinical significance of premature atrial contractions: How frequent should they become predictive of new‐onset atrial fibrillation
por: Durmaz, Eser, et al.
Publicado: (2019)

Author`s Reply
por: Barman, Hasan Ali, et al.
Publicado: (2020)

Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction
por: Barman, Hasan Ali, et al.
Publicado: (2019)

p.R220L Is a Likely Pathogenic Novel GLA Gene Mutation Responsible for Fabry Disease
por: Ali Barman, Hasan, et al.
Publicado: (2022)

Relation between serum sodium levels and clinical outcomes in Turkish patients hospitalized for heart failure: a multi-center retrospective observational study
por: Avcı, Burçak Kılıçkıran, et al.
Publicado: (2017)

Fabry Disease Presenting with Hypertrophic Cardiomyopathy and Tricuspid Regurgitation
por: Cho, Sang-Cheol, et al.
Publicado: (2016)

Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy
por: Vijapurapu, Ravi, et al.
Publicado: (2022)

Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
por: Stankowski, Kamil, et al.
Publicado: (2023)

Early Changes in Atrial Electromechanical Coupling in Patients with Hypertension: Assessment by Tissue Doppler Imaging
por: Avci, Burcak Kilickiran, et al.
Publicado: (2016)

Nationwide screening of Fabry disease in patients with hypertrophic cardiomyopathy in Czech Republic
por: Zemánek, David, et al.
Publicado: (2022)

Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
por: Frustaci, Andrea, et al.
Publicado: (2023)

Hb Andrew-Minneapolis Variant in a Turkish Family
por: Sümter, Hamza, et al.
Publicado: (2023)

Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy
por: Müntze, Jonas, et al.
Publicado: (2018)

Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope
por: Atıcı, Adem, et al.
Publicado: (2019)

Mitochondrial membrane protein-associated neurodegeneration in a Turkish patient
por: Incecik, Faruk, et al.
Publicado: (2016)

GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
por: Chaves-Markman, Ândrea Virgínia, et al.
Publicado: (2019)

Fabry Cardiomyopathy
por: Yoon, Jae Yong, et al.
Publicado: (2013)

Risk assessment and survival of patients with pulmonary hypertension: Multicenter experience in Turkey
por: Yaylalı, Yalın Tolga, et al.
Publicado: (2019)

Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey
por: Barman, Hasan Ali, et al.
Publicado: (2020)

Diagnostic Clues for the Diagnosis of Nonsarcomeric Hypertrophic Cardiomyopathy (Phenocopies): Amyloidosis, Fabry Disease, and Mitochondrial Disease
por: Limongelli, Giuseppe, et al.
Publicado: (2018)

Description of a New GLA Gene Variant in a Patient with Hypertrophic Cardiomyopathy. Is it Fabry Disease?
por: Bittencourt, Marcelo Imbroinise
Publicado: (2019)

Prognostic value of right ventricular strain pattern on ECG in COVID-19 patients
por: Barman, Hasan Ali, et al.
Publicado: (2021)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
por: Yaylalı, Yalın Tolga, et al.
Publicado: (2023)

Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?
por: Aladağ, N, et al.
Publicado: (2023)

GNE Myopathy in Turkish Sisters with a Novel Homozygous Mutation
por: Diniz, Gulden, et al.
Publicado: (2016)

Fabry Disease that Phenocopies Hypertrophic Cardiomyopathy: a thorough Genetic ‘Detective’ Identifies the ‘Rogue’ Hidden in the GLA Gene
por: Kwon, Soonil, et al.
Publicado: (2019)

A Case of Fabry Cardiomyopathy
por: Nah, Jong Chun, et al.
Publicado: (2009)

Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography
por: Baycan, Omer Faruk, et al.
Publicado: (2020)

Clinical and molecular findings in 37 Turkish patients with isolated methylmalonic acidemia
por: ŞEKER YILMAZ, Berna, et al.
Publicado: (2021)

Amiodarone-related blue–gray skin discoloration
por: Atıcı, Adem, et al.
Publicado: (2019)

The effect of the severity COVID-19 infection on electrocardiography
por: Barman, Hasan Ali, et al.
Publicado: (2021)

The assessment of the relationship between variations in the apelin gene and coronary artery disease in Turkish population
por: Pakizeh, Ebrahim, et al.
Publicado: (2015)

Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy
por: Ulus, Taner, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Reliability and validity of the Turkish version of the WHO-5, in adults and older adults for its use in primary care settings
por: Eser, Erhan, et al.
Publicado: (2019)

Assessment of increased risk of arrhythmia in advanced age pregnancies
por: Aslan, Mehmet Musa, et al.
Publicado: (2018)

Simple electrocardiographic parameters predicting risk of hypertrophic cardiomyopathy: Too simple?
por: Çay, Serkan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k6d4lde9hmqom8s2d4ecaldkml